ATNM Actinium Pharmaceuticals, Inc.

Fundamentals / CIK 0001388320 / USD

Actinium Pharmaceuticals, Inc. reported $90K in revenue and net income of $10.60M for the fiscal year ended December 31, 2025, with a 10140.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATNM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$6.28M$3.14M$0-$45.74MFY 2016 Net Income: -$24.32M2016FY 2017 Net Income: -$26.60M2017FY 2018 Net Income: -$23.65M2018FY 2019 Net Income: -$21.90M2019FY 2020 Net Income: -$22.21M2020FY 2021 Revenue: $1.14MFY 2021 Net Income: -$24.77M2021FY 2022 Revenue: $1.03MFY 2022 Net Income: -$33.02M2022FY 2023 Revenue: $81KFY 2023 Net Income: -$48.82M2023FY 2024 Net Income: -$38.24M2024FY 2025 Revenue: $90KFY 2025 Net Income: -$33.89M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $90K -- $81K $1.03M $1.14M -- -- -- -- --
Cost of Revenue -- -- -- -- $900K -- -- -- -- --
Gross Profit -- -- -- -- $244K -- -- -- -- --
Research & Development $21.12M $30.05M $38.67M $23.14M $18.03M $16.09M $16.55M $17.09M $17.72M $17.83M
Total Operating Expenses $36.34M $42.12M $52.00M $35.13M $26.11M $22.39M $22.07M $23.83M $26.91M $26.85M
Operating Income -$36.25M -$42.12M -$51.92M -$34.10M -$24.96M -$22.39M -$22.07M -$23.83M -$26.91M -$26.85M
EBITDA -$36.07M -$41.92M -$51.71M -$33.41M -$24.44M -$21.95M -$21.65M -$23.78M -$26.85M -$26.77M
Interest Income $2.36M $3.88M $3.10M -- -- -- -- -- -- --
Interest Expense -- -- -- -- -- -- -- -- -- $5.0K
Net Income -$33.89M -$38.24M -$48.82M -$33.02M -$24.77M -$22.21M -$21.90M -$23.65M -$26.60M -$24.32M
Basic EPS -$1.09 -$1.27 -$1.83 -$1.37 -$1.20 -$1.83 -$4.40 -$0.22 -$0.40 -$0.50
Diluted EPS -$1.09 -$1.27 -$1.83 -$1.37 -$1.20 -$1.83 -$4.40 -$0.22 -$0.40 -$0.50
Basic Shares Outstanding 31.2M 30.1M 26.6M 24.1M 20.6M 12.1M 5.0M 106.0M 66.7M 48.5M
Diluted Shares Outstanding 31.2M 30.1M 26.6M 24.1M 20.6M 12.1M 5.0M 106.0M 66.7M 48.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- $35.00M -- -- $90K -- -- --
Research & Development $4.71M $5.38M $4.20M $4.30M $4.25M $4.88M $7.70M $4.81M
Total Operating Expenses $6.12M $7.43M $5.90M $6.41M $5.78M $7.50M $16.64M $7.50M
Operating Income -$6.12M $27.57M -$5.90M -$6.41M -$5.69M -$7.50M -$16.64M -$7.50M
EBITDA -$5.90M $28.00M -$5.87M -$6.86M -$5.49M -$7.14M -$16.59M -$7.92M
Interest Income $279K $336K $381K $474K $561K $625K $700K $853K
Net Income -$5.84M $27.90M -$5.52M -$5.94M -$5.13M -$6.88M -$15.94M -$6.65M
Basic EPS -$0.19 $0.89 -$0.18 -- -$0.16 -$0.22 -$0.51 --
Diluted EPS -$0.19 $0.89 -$0.18 -- -$0.16 -$0.22 -$0.51 --
Basic Shares Outstanding 31.4M 31.4M 31.2M -- 31.2M 31.2M 31.2M --
Diluted Shares Outstanding 31.4M 31.4M 31.2M -- 31.2M 31.2M 31.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $48.00M $72.90M $76.68M $108.9M $77.83M $63.56M $9.25M $13.67M $17.40M $20.52M
Cash & Short-Term Investments $48.00M $72.90M $76.68M $108.9M $77.83M $63.56M $9.25M $13.67M $17.40M $20.52M
Other Current Assets $168K $357K $226K $65K -- -- -- -- -- --
Total Current Assets $49.38M $74.51M $78.26M $110.9M $79.75M $64.92M $10.09M $14.33M $17.84M $22.39M
Property, Plant & Equipment, Net $295K $364K $550K $604K $340K $312K $113K $119K $57K $89K
Goodwill -- -- -- -- -- -- -- -- -- $100K
Total Non-Current Assets $2.39M $2.39M $3.18M $3.25M $639K $1.47M $1.58M $560K $498K $138K
Total Assets $51.77M $76.90M $81.44M $114.2M $80.39M $66.40M $11.67M $14.89M $18.34M $22.53M
Deferred Revenue (Current) -- -- -- -- $1.00M -- -- -- -- --
Other Current Liabilities -- -- -- -- $998K -- -- -- -- --
Total Current Liabilities $7.97M $8.15M $8.49M $10.63M $6.84M $4.77M $5.34M $6.06M $4.67M $4.52M
Long-Term Debt -- -- -- -- -- -- $900K -- -- --
Deferred Revenue (Non-Current) $35.00M $35.00M $35.00M $35.00M -- -- -- -- -- --
Total Non-Current Liabilities $35.97M $35.99M $36.57M $37.08M $3.0K $311K $682K $13K $0 $0
Total Liabilities $43.94M $44.14M $45.07M $47.71M $6.84M $5.08M $6.03M $6.08M $4.67M $4.52M
Total Debt (incl. Leases) $1.69M $1.57M $2.11M $2.58M $310K $427K $1.19M $16K -- --
Common Stock $31K $31K $28K $26K $22K $18K $5.0K $116K $80K $56K
Retained Earnings -$409.7M -$375.8M -$337.6M -$288.8M -$255.7M -$231.0M -$208.8M -$186.9M -$163.2M -$136.6M
Accumulated Other Comp. Income -$20K -- -- -- -- -- -- -- -- --
Total Stockholders' Equity $7.83M $32.76M $36.38M $66.48M $73.55M $61.32M $5.64M $8.81M $13.67M $18.01M
Total Equity $7.83M $32.76M $36.38M $66.48M $73.55M $61.32M $5.64M $8.81M $13.67M $18.01M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $28.68M $36.47M $42.13M $48.00M $53.39M $59.93M $65.33M $72.90M
Cash & Short-Term Investments $28.68M $36.47M $42.13M $48.00M $53.39M $59.93M $65.33M $72.90M
Other Current Assets -- -- -- $168K -- -- -- $357K
Total Current Assets $29.49M $37.74M $43.26M $49.38M $54.37M $61.03M $66.46M $74.51M
Property, Plant & Equipment, Net $1.45M $700K $268K $295K $226K $271K $317K $364K
Total Non-Current Assets $2.97M $2.42M $2.18M $2.39M $1.78M $1.99M $2.19M $2.39M
Total Assets $32.47M $40.16M $45.44M $51.77M $56.15M $63.02M $68.65M $76.90M
Total Current Liabilities $7.37M $9.26M $7.35M $7.97M $6.83M $8.31M $7.11M $8.15M
Deferred Revenue (Non-Current) -- -- $35.00M $35.00M $35.00M $35.00M $35.00M $35.00M
Total Non-Current Liabilities $510K $595K $35.78M $35.97M $35.53M $35.69M $35.84M $35.99M
Total Liabilities $7.88M $9.86M $43.13M $43.94M $42.37M $44.00M $42.95M $44.14M
Total Debt (incl. Leases) $1.16M $1.34M $1.52M $1.69M $1.14M $1.29M $1.43M $1.57M
Common Stock $31K $31K $31K $31K $31K $31K $31K $31K
Retained Earnings -$393.2M -$387.3M -$415.2M -$409.7M -$403.8M -$398.6M -$391.8M -$375.8M
Accumulated Other Comp. Income -$70K -$60K -$39K -$20K -- -- -- --
Total Stockholders' Equity $24.59M $30.30M $2.30M $7.83M $13.78M $19.01M $25.69M $32.76M
Total Equity $24.59M $30.30M $2.30M $7.83M $13.78M $19.01M $25.69M $32.76M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$33.89M -$38.24M -$48.82M -$33.02M -$24.77M -$22.21M -$21.90M -$23.65M -$26.60M -$24.32M
Depreciation & Amortization $173K $197K $207K $699K $524K $447K $420K $51K $56K $78K
Stock-Based Compensation $9.19M $5.29M $3.84M $2.79M $1.69M $1.25M $1.29M $1.80M $3.49M $4.30M
Operating Cash Flow -$24.58M -$33.07M -$47.34M $8.64M -$20.87M -$21.62M -$21.46M -$20.57M -$21.55M -$20.79M
Capital Expenditure -$104K -$11K -$153K -$366K -$133K -$253K -$64K -$96K -$25K -$60K
Free Cash Flow -$24.68M -$33.08M -$47.49M $8.28M -$21.00M -$21.87M -$21.53M -$20.67M -$21.58M -$20.85M
Purchases of Investments -- -- -- -- -- -- -- -- -- -$50K
Investing Cash Flow -$104K -$11K -$153K -$366K -$133K -$253K -$64K -$96K -$25K -$110K
Common Stock Issued -- $29.25M $14.61M $23.16M $35.30M $76.59M $15.93M $16.98M $18.81M $16.02M
Financing Cash Flow -$217K $29.32M $14.87M $23.11M $35.22M $76.18M $17.11M $16.98M $18.81M $15.78M
Net Change in Cash -$24.89M -$3.76M -$32.62M $31.39M $14.22M $54.31M -$4.41M -$3.69M -$2.76M -$5.12M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.84M $27.90M -$5.52M -$5.94M -$5.13M -$6.88M -$15.94M -$6.65M
Depreciation & Amortization $218K $432K $29K -$442K $206K $362K $47K -$410K
Stock-Based Compensation $136K $118K $11K $10K $109K $197K $8.87M $1.20M
Operating Cash Flow -$7.02M -$5.18M -$5.87M -$5.29M -$6.33M -$5.39M -$7.57M -$5.75M
Capital Expenditure -$770K -$478K -$2.0K -- -- -- -- $0
Free Cash Flow -$7.79M -$5.66M -$5.87M -- -- -- -- -$5.75M
Investing Cash Flow -$770K -$478K -$2.0K -- -- -- -- $0
Common Stock Issued -- -- -- -- -- -- -- -$1.0K
Financing Cash Flow -$3.0K -$2.0K -$3.0K -$3.0K -$209K -$3.0K -$2.0K -$3.0K
Net Change in Cash -$7.79M -$5.66M -$5.86M -$5.39M -$6.53M -$5.39M -$7.58M -$5.75M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- 21.3% -- -- -- -- --
Operating Margin -40274.4% -- -64098.8% -3311.1% -2182.2% -- -- -- -- --
Net Profit Margin -37652.2% -- -60269.1% -3205.5% -2165.6% -- -- -- -- --
Return on Equity (ROE) -432.6% -116.7% -134.2% -49.7% -33.7% -36.2% -388.0% -268.4% -194.6% -135.1%
Return on Assets (ROA) -65.5% -49.7% -59.9% -28.9% -30.8% -33.5% -187.7% -158.9% -145.1% -108.0%
Current Ratio 6.20x 9.14x 9.21x 10.44x 11.66x 13.62x 1.89x 2.36x 3.82x 4.95x
Quick Ratio 6.02x 8.95x 9.03x 10.25x 11.38x 13.33x 1.73x 2.26x 3.73x 4.54x
Debt to Equity 0.22x 0.05x 0.06x 0.04x 0.00x 0.01x 0.21x 0.00x -- --
Revenue Growth (YoY) -- -- -92.1% -10.0% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -647.6% -- -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -673.7% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) 43.1% 37.3% -1018.7% -432.6% -251.0% -215.8% -177.1% -116.7%
Return on Assets (ROA) 32.6% 28.2% -51.7% -65.5% -61.6% -65.1% -66.3% -49.7%
Current Ratio 4.00x 4.08x 5.89x 6.20x 7.96x 7.34x 9.35x 9.14x
Quick Ratio 3.89x 3.94x 5.73x 6.02x 7.81x 7.21x 9.19x 8.95x
Debt to Equity 0.05x 0.04x 0.66x 0.22x 0.08x 0.07x 0.06x 0.05x
Source: SEC EDGAR CompanyFacts (CIK 0001388320) · from December 31, 2001 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal